The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Adverse effects of long-term amiodarone therapy

  • Park, Hyoung-Seob (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center) ;
  • Kim, Yoon-Nyun (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center)
  • Received : 2014.07.28
  • Accepted : 2014.07.31
  • Published : 2014.09.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Kim HL, Seo JB, Chung WY, Kim SH, Kim MA, Zo JH. The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice. Korean J Intern Med 2014;29:588-596. https://doi.org/10.3904/kjim.2014.29.5.588
  2. Goldschlager N, Epstein AE, Naccarelli GV, et al. A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm 2007;4:1250-1259. https://doi.org/10.1016/j.hrthm.2007.07.020
  3. Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997;30:791-798. https://doi.org/10.1016/S0735-1097(97)00220-9
  4. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417-1424. https://doi.org/10.1016/S0140-6736(97)05281-1
  5. Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990;82:51-59. https://doi.org/10.1161/01.CIR.82.1.51
  6. Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med 2005;118:706-714. https://doi.org/10.1016/j.amjmed.2004.11.028
  7. Mantyjarvi M, Tuppurainen K, Ikaheimo K. Ocular side effects of amiodarone. Surv Ophthalmol 1998;42:360-366. https://doi.org/10.1016/S0039-6257(97)00118-5
  8. Cho YK, Kim YN, Han SW, et al. Clinical reviews about overall incidence of adverse effects in amiodarone treatment. Keimyung Med J 2007;26:87-95.
  9. Hohnloser SH, Crijns HJ, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-678. https://doi.org/10.1056/NEJMoa0803778
  10. Le Heuzey JY, De Ferrari GM, Radzik D, Santini M, Zhu J, Davy JM. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. J Cardiovasc Electrophysiol 2010;21:597-605. https://doi.org/10.1111/j.1540-8167.2010.01764.x

Cited by

  1. Chinese herbal medicine for patients with atrial fibrillation: protocol for a systematic review and meta-analysis vol.96, pp.50, 2014, https://doi.org/10.1097/md.0000000000009228
  2. Insulin-like growth factor-1 activates PI3K/Akt signalling to protect human retinal pigment epithelial cells from amiodarone-induced oxidative injury : IGF-1 prevents amiodarone-induced oxidative inju vol.175, pp.1, 2014, https://doi.org/10.1111/bph.14078
  3. Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection vol.8, pp.None, 2014, https://doi.org/10.1177/2324709620925571
  4. Long-term Outcome of Pulmonary Vein Isolation Versus Amiodarone Therapy in Patients with Coexistent Persistent AF and Congestive Heart Failure vol.6, pp.None, 2014, https://doi.org/10.15420/cfr.2019.03
  5. Amiodarone-induced sudden onset of polymorphic ventricular tachycardia following dislodgement of a temporary pacemaker: a case report vol.36, pp.6, 2014, https://doi.org/10.1007/s40267-020-00729-7
  6. Levetiracetam for the treatment of myoclonic neurotoxicity induced by amiodarone vol.6, pp.8, 2014, https://doi.org/10.1016/j.hrcr.2020.04.010
  7. Amiodarone, Unlike Dronedarone, Activates Inflammasomes via Its Reactive Metabolites: Implications for Amiodarone Adverse Reactions vol.34, pp.8, 2014, https://doi.org/10.1021/acs.chemrestox.1c00127
  8. Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning vol.15, pp.1, 2022, https://doi.org/10.3390/ph15010031